{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:16:07Z","timestamp":1778883367187,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006293","name":"American Society of Clinical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006293","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","award":["Y-2019AZMS-1045"],"award-info":[{"award-number":["Y-2019AZMS-1045"]}],"id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","award":["Y-HS202301-0057"],"award-info":[{"award-number":["Y-HS202301-0057"]}],"id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ctro.2025.101038","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T14:26:50Z","timestamp":1756045610000},"page":"101038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic factors, patterns of failure and re-irradiation in hypofractionated stereotactic radiotherapy-treated brain metastases from non-small cell lung cancer"],"prefix":"10.1016","volume":"55","author":[{"given":"Dayu","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yechun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengfei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3113-2586","authenticated-orcid":false,"given":"Jianjiao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ctro.2025.101038_b0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11912-018-0695-9","article-title":"Emerging trends in the management of brain metastases from non-small cell lung cancer","volume":"20","author":"Churilla","year":"2018","journal-title":"Curr Oncol Rep"},{"issue":"14","key":"10.1016\/j.ctro.2025.101038_b0010","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101038_b0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0169-5002(00)00227-0","article-title":"Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation","volume":"32","author":"Rodrigus","year":"2001","journal-title":"Lung Cancer"},{"issue":"32","key":"10.1016\/j.ctro.2025.101038_b0020","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.20.01255","article-title":"Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient","volume":"38","author":"Sperduto","year":"2020","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.ctro.2025.101038_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312654","article-title":"Blood-brain barrier in brain tumors: biology and clinical relevance","volume":"22","author":"Mo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ctro.2025.101038_b0030","article-title":"Whole brain radiotherapy for brain metastases","volume":"355","author":"Brown","year":"2016","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.ctro.2025.101038_b0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1200\/JOP.2016.012922","article-title":"Stereotactic radiosurgery for treatment of brain metastases","volume":"12","author":"Badiyan","year":"2016","journal-title":"J Oncol Pract"},{"issue":"21","key":"10.1016\/j.ctro.2025.101038_b0040","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.ctro.2025.101038_b0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101038_b0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ctro.2025.101038_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2019.12.019","article-title":"Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic\/oligoprogressive non-small cell lung cancer patients: results of a multi-institutional series of 198 patients treated with \u201ccurative\u201d intent","volume":"141","author":"Buglione","year":"2020","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.ctro.2025.101038_b0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","article-title":"Radiation therapy for brain metastases: an ASTRO clinical practice guideline","volume":"12","author":"Gondi","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2025.101038_b0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2025.101038_b0070","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11060-012-0808-5","article-title":"Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases","volume":"108","author":"Ogiwara","year":"2012","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.ctro.2025.101038_b0080","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00066-016-0963-2","article-title":"Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer: Evaluation of indications and predictors of local control","volume":"192","author":"Ishihara","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2025.101038_b0085","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13014-016-0653-3","article-title":"Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection","volume":"11","author":"Navarria","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101038_b0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-717X-7-36","article-title":"Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters","volume":"7","author":"Jiang","year":"2012","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101038_b0095","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ijrobp.2016.03.013","article-title":"Single-fraction versus multifraction (3 x 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis","volume":"95","author":"Minniti","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2025.101038_b0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11060-012-0912-6","article-title":"Outcomes of hypofractionated stereotactic radiotherapy for metastatic brain tumors with high risk factors","volume":"109","author":"Ogura","year":"2012","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11060-015-1937-4","article-title":"Repeated stereotactic radiosurgery for patients with progressive brain metastases","volume":"126","author":"Minniti","year":"2016","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.ctro.2025.101038_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030996","article-title":"Re-irradiation by stereotactic radiotherapy of brain metastases in the case of local recurrence","volume":"15","author":"Touati","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13014-022-02194-0","article-title":"Acute toxicities and cumulative dose to the brain of repeated sessions of stereotactic radiotherapy (SRT) for brain metastases: a retrospective study of 184 patients","volume":"18","author":"Kuntz","year":"2023","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12885-023-10761-1","article-title":"SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases","volume":"23","author":"Crouzen","year":"2023","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ctro.2025.101038_b0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/neuonc\/noaa233","article-title":"Population-based estimates of survival among elderly patients with brain metastases","volume":"23","author":"Lamba","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ctro.2025.101038_b0130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejca.2021.10.006","article-title":"Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutations","volume":"159","author":"Vassella","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctro.2025.101038_b0135","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.78.3118","article-title":"CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer","author":"Reungwetwattana","year":"2018","journal-title":"J Clin Oncol"},{"issue":"26","key":"10.1016\/j.ctro.2025.101038_b0140","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1200\/JCO.2018.77.9363","article-title":"CNS Efficacy of osimertinib in patients with T790M-positive advanced non-small-cell lung cancer: data from a randomized phase III trial (AURA3)","volume":"36","author":"Wu","year":"2018","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2025.101038_b0145","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/ijc.33904","article-title":"Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant nonsmall cell lung cancer with brain metastasis","volume":"150","author":"Zhao","year":"2022","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4143\/crt.2024.223","article-title":"Upfront Stereotactic radiosurgery or fractionated stereotactic radiotherapy in elderly patients with brain metastases from non-small cell lung cancer: a retrospective analysis of a 10-year bi-institutional experience","volume":"57","author":"Kim","year":"2025","journal-title":"Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","article-title":"Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain","volume":"110","author":"Milano","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0160","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3171\/2016.5.JNS153051","article-title":"Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery","volume":"127","author":"McKay","year":"2017","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.ctro.2025.101038_b0165","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ijrobp.2021.10.008","article-title":"Reirradiation with stereotactic radiosurgery after local or marginal recurrence of brain metastases from previous radiosurgery","volume":"112","author":"Kowalchuk","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11060-013-1191-6","article-title":"Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery","volume":"115","author":"Kim","year":"2013","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.ctro.2025.101038_b0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cllc.2023.01.002","article-title":"Upfront and repeated stereotactic radiosurgery in patients with brain metastases from NSCLC","volume":"24","author":"Kramer","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ctro.2025.101038_b0180","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3389\/fonc.2018.00551","article-title":"Repeated courses of radiosurgery for new brain metastases to defer whole brain radiotherapy: feasibility and outcome with validation of the new prognostic metric brain metastasis velocity","volume":"8","author":"Fritz","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2025.101038_b0185","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3389\/fonc.2019.01352","article-title":"Stereotactic Radiation Therapy (SRT) for brain metastases of multiple primary tumors: a single institution retrospective analysis","volume":"9","author":"Gu","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2025.101038_b0190","first-page":"1","article-title":"Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: evaluation of predictive factors","volume":"36","author":"Leyrat","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101038_b0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijrobp.2017.04.006","article-title":"Single-fraction stereotactic radiosurgery (SRS) alone versus surgical resection and SRS for large brain metastases: a multi-institutional analysis","volume":"99","author":"Prabhu","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2025.101038_b0200","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/neuonc\/noy159","article-title":"Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose","volume":"21","author":"Moraes","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ctro.2025.101038_b0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.radonc.2020.12.011","article-title":"Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastases","volume":"156","author":"Andruska","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2023.07.040","article-title":"Dose-volume tolerance of the brain and predictors of radiation necrosis after 3-fraction radiosurgery for brain metastases: a large single-institutional analysis","volume":"118","author":"Upadhyay","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.101038_b0215","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13014-015-0525-2","article-title":"Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases","volume":"10","author":"Lischalk","year":"2015","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101038_b0220","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ijrobp.2012.09.008","article-title":"Clinical outcomes of biological effective dose-based fractionated stereotactic radiation therapy for metastatic brain tumors from non-small cell lung cancer","volume":"85","author":"Matsuyama","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijrobp.2020.10.034","article-title":"Tumor control probability of radiosurgery and fractionated stereotactic radiosurgery for brain metastases","volume":"110","author":"Redmond","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2025.101038_b0230","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.radonc.2011.01.011","article-title":"Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review","volume":"98","author":"Wiggenraad","year":"2011","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101038_b0235","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11060-018-2885-6","article-title":"Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED(10)","volume":"139","author":"Kumar","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ctro.2025.101038_b0240","article-title":"Pretreatment lymphocyte-to-monocyte ratio as a prognostic factor and influence on dose-effect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2025.101038_b0245","doi-asserted-by":"crossref","unstructured":"Khalifa J, Amini A, Popat S, Gaspar LE, Faivre-Finn C.; International Association for the Study of Lung Cancer Advanced Radiation Technology, C. Brain metastases from NSCLC: radiation therapy in the era of targeted therapies. J Thorac Oncol 2016, 11 (10), 1627\u201343.","DOI":"10.1016\/j.jtho.2016.06.002"},{"issue":"4","key":"10.1016\/j.ctro.2025.101038_b0250","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ijrobp.2017.11.041","article-title":"Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma","volume":"100","author":"Chen","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0255","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13014-020-01644-x","article-title":"Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases","volume":"15","author":"Kowalski","year":"2020","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2025.101038_b0260","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11060-022-04038-z","article-title":"Local and distant brain control in melanoma and NSCLC brain metastases with concurrent radiosurgery and immune checkpoint inhibition","volume":"158","author":"Le","year":"2022","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101038_b0265","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0360-3016(03)00568-6","article-title":"Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases","volume":"57","author":"Varlotto","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2025.101038_b0270","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijrobp.2014.05.047","article-title":"Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases","volume":"90","author":"Garsa","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2025.101038_b0275","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2012.05.047","article-title":"Predictors of survival in contemporary practice after initial radiosurgery for brain metastases","volume":"85","author":"Likhacheva","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0280","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13014-022-02185-1","article-title":"Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases","volume":"17","author":"Hirata","year":"2022","journal-title":"Radiat Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2025.101038_b0285","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s12094-020-02544-y","article-title":"Efficacy of salvage stereotactic radiotherapy (SRT) for locally recurrent brain metastases after initial SRT and characteristics of target population","volume":"23","author":"Holub","year":"2021","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101038_b0290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13014-023-02200-z","article-title":"Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients","volume":"18","author":"Kuntz","year":"2023","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101038_b0295","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ijrobp.2009.06.006","article-title":"Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery","volume":"77","author":"Blonigen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:47:28Z","timestamp":1778881648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630825001302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":59,"alternative-id":["S2405630825001302"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101038","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors, patterns of failure and re-irradiation in hypofractionated stereotactic radiotherapy-treated brain metastases from non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101038"}}